Roberto Cristodulo
Roberto Cristodulo has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Barbagelata
Universidad Catolica Argentina, Buenos Aires, Argentina; Duke University, Durham, NC, USA
3 shared publications Carlos Vaca
Hospital Obrero N.° 3 Caja Nacional de Salud, Santa Cruz de la Sierra, Estado Plurinacional de Bolivia, Bolivia
2 shared publications- Juan Manuel Vaca Villarroel
Hospital Municipal Frances, Santa Cruz de la Sierra - Bolivia
2 shared publications Alejandro Barbagelata
Universidad Católica Argentina - Duke University School of Medicine, USA
1 shared publication- Bozorg Zonneveld
Clínica de las Américas, Santa Cruz
1 shared publication Daniela Ureña
Hospital Obrero N.° 3 Caja Nacional de Salud, Santa Cruz de la Sierra, Estado Plurinacional de Bolivia, Bolivia
1 shared publication
Latest Publications
- 19 August 2025
- Published by Elsevier in The American Journal of Cardiology
- Vol. 255, 126-133
Clinical and Epidemiological Profile of Heart Failure Patients With Chagas Disease: Insights From the SEPE-HF Registry
- 19 August 2025
- Published by Elsevier in The American Journal of Cardiology
- Vol. 255, 126-133
Clinical and Epidemiological Profile of Heart Failure Patients With Chagas Disease: Insights From the SEPE-HF Registry
- Open Access
- 16 May 2025
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
Registro de insuficiencia cardíaca en Santa Cruz de la Sierra, Bolivia. Registro SEPE-HF
Introducción: La insuficiencia cardíaca es una verdadera pandemia, con más de 64 millones de personas con este síndrome en todo el mundo. Realizamos un registro de insuficiencia cardíaca en Santa Cruz de la Sierra – Bolivia, el REGISTRO SEPE-HF. Objetivos: determinar las características epidemiológicas, clínica, evaluación, tratamiento y pronóstico de la insuficiencia cardíaca en nuestra región. Material y métodos: Desde enero 2023 hasta abril 2024 fueron incluidos pacientes con historia de insuficiencia cardíaca internados por dicha causa en 7 centros participantes. Resultados: Se incluyeron 418 pacientes, el 49% hombres, con una media de edad de 67,4 ± 13,1 años. Tenía antecedentes de hipertensión arterial el 64%, de diabetes mellitus el 21%, de fibrilación auricular un 20%, de cardiopatía isquémica el 12%. La predominante fue la chagásica (37%). En el ecocardiograma transtorácico el 51% presentaba fracción de eyección ventricular izquierda menor de 40%. La incidencia de mortalidad cardiovascular fue del 5,5%. Se observaron similitudes en cuanto a nues-tra incidencia en muchos factores epidemiológicos, comorbilidades, perfil clínico y ecocardiograma con el Registro argentino de internación por insuficiencia cardíaca ARGEN-IC. Conclusión: El registro SEPE refleja las características y evolución de los pacientes internados por insuficiencia cardíaca en Santa Cruz de la Sierra, Bolivia. La etiología chagásica es responsable de más de un tercio de los casos, lo que hace imprescindible avanzar en el desarrollo de medidas que favorezcan el diagnóstico precoz de la afección y la erradicación de la endemia.
- 16 May 2025
- Published by Revista Argentina de Cardiologia in Revista Argentina de Cardiologia
Open AccessRegistro de insuficiencia cardíaca en Santa Cruz de la Sierra, Bolivia. Registro SEPE-HF
Introducción: La insuficiencia cardíaca es una verdadera pandemia, con más de 64 millones de personas con este síndrome en todo el mundo. Realizamos un registro de insuficiencia cardíaca en Santa Cruz de la Sierra – Bolivia, el REGISTRO SEPE-HF. Objetivos: determinar las características epidemiológicas, clínica, evaluación, tratamiento y pronóstico de la insuficiencia cardíaca en nuestra región. Material y métodos: Desde enero 2023 hasta abril 2024 fueron incluidos pacientes con historia de insuficiencia cardíaca internados por dicha causa en 7 centros participantes. Resultados: Se incluyeron 418 pacientes, el 49% hombres, con una media de edad de 67,4 ± 13,1 años. Tenía antecedentes de hipertensión arterial el 64%, de diabetes mellitus el 21%, de fibrilación auricular un 20%, de cardiopatía isquémica el 12%. La predominante fue la chagásica (37%). En el ecocardiograma transtorácico el 51% presentaba fracción de eyección ventricular izquierda menor de 40%. La incidencia de mortalidad cardiovascular fue del 5,5%. Se observaron similitudes en cuanto a nues-tra incidencia en muchos factores epidemiológicos, comorbilidades, perfil clínico y ecocardiograma con el Registro argentino de internación por insuficiencia cardíaca ARGEN-IC. Conclusión: El registro SEPE refleja las características y evolución de los pacientes internados por insuficiencia cardíaca en Santa Cruz de la Sierra, Bolivia. La etiología chagásica es responsable de más de un tercio de los casos, lo que hace imprescindible avanzar en el desarrollo de medidas que favorezcan el diagnóstico precoz de la afección y la erradicación de la endemia.
- Open Access
- 4 August 2023
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 18 (1) , 41
Dengue Myocarditis: A Case Report and Major Review
Dengue is a viral disease transmitted by the bite of a female arthropod, prevalent primarily in tropical and subtropical regions. Its manifestations include asymptomatic infections, dengue fever, and a severe form called hemorrhagic dengue or dengue shock syndrome. Atypical manifestations can also occur, called expanded dengue syndrome. We describe the case of a 43-year-old man with an unusual presentation of dengue, demonstrating a workup suggestive of myocardial and pericardial damage. Symptoms and markers indicative of cardiac compromise improved after five days on anti-inflammatory treatment. Dengue myocarditis is considered an uncommon complication of dengue, although its reported incidence is likely an underestimation. In general, most cases of dengue myocarditis are self-limited, with only a minority at risk of progressing to heart failure. In order to improve recognition and prevent progression, healthcare providers should maintain a high degree of suspicion regarding potential cardiac complications in patients with dengue.
- 4 August 2023
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 18 (1) , 41
Open AccessDengue Myocarditis: A Case Report and Major Review
Dengue is a viral disease transmitted by the bite of a female arthropod, prevalent primarily in tropical and subtropical regions. Its manifestations include asymptomatic infections, dengue fever, and a severe form called hemorrhagic dengue or dengue shock syndrome. Atypical manifestations can also occur, called expanded dengue syndrome. We describe the case of a 43-year-old man with an unusual presentation of dengue, demonstrating a workup suggestive of myocardial and pericardial damage. Symptoms and markers indicative of cardiac compromise improved after five days on anti-inflammatory treatment. Dengue myocarditis is considered an uncommon complication of dengue, although its reported incidence is likely an underestimation. In general, most cases of dengue myocarditis are self-limited, with only a minority at risk of progressing to heart failure. In order to improve recognition and prevent progression, healthcare providers should maintain a high degree of suspicion regarding potential cardiac complications in patients with dengue.
- Open Access
- 22 October 2021
- Published by Federacion Argentina de Cardiología in Revista de la Federación Argentina de Cardiología
- Vol. 50 (3) , 104-109
Primer registro de insuficiencia cardíaca en la caja nacional de salud
Background: Heart failure is a disease that affects millions of people around the world. A chronic phase characterization is important in Latin American countries. It is with this motivation that the authors decided to carry out a registry at hospital level to encourage better data and on a larger scale: The First Registry of Heart Failure at the Caja Nacional de Salud Hospital (PRICNASA). Method: All patients older than 18 years admitted to the cardiology ward for decompensated HF at Hospital Obrero # 3 - CNS between September 2018 and September 2019 were prospectively included. The diagnosis of HF was left at the discretion of the investigators and patients with HF were excluded due to myocardial infarction and postoperative cardiac surgery. Results: There were 194 patients admitted; the mean age was 61 years, and about 61% were male. Chagas disease was the most frequent etiology in 49% of the patients. Medication was optimized upon discharge, increasing ACEIs from 12.9% to 27.8%, beta-blockers from 39.2% to 58.8%, furosemide from 41.2% to 79.9%, and spironolactone from 22.7% to 56.2%. Regarding complications, 6.2% presented cardiogenic shock and mechanical ventilation. Patient mortality was 7.2% corresponding to 13 patients who died in the registry.Conclusions: The PRICNASA registry showed similarities in terms of incidence in many factors such as age and comorbidities. Chagas disease stands out as the main etiology in most patients and a mortality that is comparable with other realities worldwide. This first local registry will serve for future contributions to the knowledge of the pathology and its treatment at regional level within the different scenarios of the health systems. It will be a starting point to make.
- 22 October 2021
- Published by Federacion Argentina de Cardiología in Revista de la Federación Argentina de Cardiología
- Vol. 50 (3) , 104-109
Open AccessPrimer registro de insuficiencia cardíaca en la caja nacional de salud
Background: Heart failure is a disease that affects millions of people around the world. A chronic phase characterization is important in Latin American countries. It is with this motivation that the authors decided to carry out a registry at hospital level to encourage better data and on a larger scale: The First Registry of Heart Failure at the Caja Nacional de Salud Hospital (PRICNASA). Method: All patients older than 18 years admitted to the cardiology ward for decompensated HF at Hospital Obrero # 3 - CNS between September 2018 and September 2019 were prospectively included. The diagnosis of HF was left at the discretion of the investigators and patients with HF were excluded due to myocardial infarction and postoperative cardiac surgery. Results: There were 194 patients admitted; the mean age was 61 years, and about 61% were male. Chagas disease was the most frequent etiology in 49% of the patients. Medication was optimized upon discharge, increasing ACEIs from 12.9% to 27.8%, beta-blockers from 39.2% to 58.8%, furosemide from 41.2% to 79.9%, and spironolactone from 22.7% to 56.2%. Regarding complications, 6.2% presented cardiogenic shock and mechanical ventilation. Patient mortality was 7.2% corresponding to 13 patients who died in the registry.Conclusions: The PRICNASA registry showed similarities in terms of incidence in many factors such as age and comorbidities. Chagas disease stands out as the main etiology in most patients and a mortality that is comparable with other realities worldwide. This first local registry will serve for future contributions to the knowledge of the pathology and its treatment at regional level within the different scenarios of the health systems. It will be a starting point to make.